PMID: 33157425 Hollinger A, von Felten S, Sutter R, Huber J, Tran F, Reinhold S, Abdelhamid S, Todorov A, Gebhard CE, Cajochen C, Steiner LA, Siegemund M (2020) Study protocol for a prospective randomised double-blind placebo-controlled clinical trial investigating a better outcome with melatonin compared to placebo administered to normalize sleep-wake cycle and treat hypoactive ICU delirium: the Basel BOMP-AID study
Cost = C$159.99 C$2.29/mg of blended peptides , but the GHK-Cu (lower per-mg cost compound) dominates by mass
Key active ingredients include Glutathione
A recent research analyzing phase III trial data found that most approved drug combinations in oncology show additive, rather than synergistic, clinical efficacy
Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences
W.SpectorM